4-Formamidoantipyrine
Suppliers
Names
[ CAS No. ]:
1672-58-8
[ Name ]:
4-Formamidoantipyrine
[Synonym ]:
4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide
N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)carboxamide
(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imidoformic acid
4-Formylaminoantipyrine
Methanimidic acid, (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-
1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylformamide
4-Formamidoantipyrine
Formamide,N-antipyrinyl
N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)formamide
4-formyl-aminoantipyrin
Formamide, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-
4-Formylaminoantipyrine (N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide
4-formaminoantipyrine
N-Formyl-4-aminoantipyrine
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
374.5±52.0 °C at 760 mmHg
[ Melting Point ]:
189-192ºC
[ Molecular Formula ]:
C12H13N3O2
[ Molecular Weight ]:
231.251
[ Flash Point ]:
180.3±30.7 °C
[ Exact Mass ]:
231.100784
[ PSA ]:
56.03000
[ LogP ]:
0.41
[ Vapour Pressure ]:
0.0±0.9 mmHg at 25°C
[ Index of Refraction ]:
1.609
[ Storage condition ]:
Refrigerator
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ Precautionary Statements ]:
P301 + P312 + P330
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
20/22
[ RIDADR ]:
NONH for all modes of transport
[ HS Code ]:
2933199090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2933199090
[ Summary ]:
2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
J. Pharm. Biomed. Anal. 71 , 173-8, (2012)
In order to evaluate the pharmacokinetics of metamizol in the presence of morphine in arthritic rats, after subcutaneous administration of the drugs, an easy, rapid, sensitive and selective analytical...
Eur. J. Clin. Pharmacol. 57(6-7) , 461-5, (2001)
We previously found that, compared with healthy subjects. asymptomatic hepatitis-B virus (HBV) carriers displaying slow acetylator phenotype demonstrate a significant prolongation of the elimination h...
J. Chromatogr. A. 421(1) , 198-205, (1987)